Serum cytokine analysis in a cohort of advanced non-small cell lung cancer treated with PD-1 inhibitors reveals predictive markers of CXCL12

BACKGROUND: The circulating predictive factors for the outcomes of advanced non-small cell lung cancer (NSCLC) patients receiving immune checkpoint inhibitors (ICIs) remain elusive. We aimed to assess the predictive value of circulating cytokines for outcomes. METHODS: Serum samples of 102 advanced-...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yanjun, Ding, Ling, Li, Hui, Peng, Zhongsheng, Ding, Kaibo, Huang, Zhiyu, Zhou, Zichao, Xie, Mingying, Yan, Junrong, Feng, Sijie, Fan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288851/
https://www.ncbi.nlm.nih.gov/pubmed/37359565
http://dx.doi.org/10.3389/fimmu.2023.1194123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288851/
https://www.ncbi.nlm.nih.gov/pubmed/37359565
http://dx.doi.org/10.3389/fimmu.2023.1194123

Ejemplares similares